{"id":6468,"date":"2015-10-16T09:40:00","date_gmt":"2015-10-16T09:40:00","guid":{"rendered":"https:\/\/drogriporter.hu\/hungarian-researchers-aim-to-study-dmts-role-in-clinical-death\/"},"modified":"2022-07-04T14:31:15","modified_gmt":"2022-07-04T12:31:15","slug":"hungarian-researchers-aim-to-study-dmts-role-in-clinical-death","status":"publish","type":"post","link":"https:\/\/drogriporter.hu\/en\/hungarian-researchers-aim-to-study-dmts-role-in-clinical-death\/","title":{"rendered":"Hungarian Researchers Aim to Study DMT\u2019s Role in Clinical Death"},"content":{"rendered":"

Scientists at the University of Debrecen, Hungary, are aiming to work on cutting-edge research to study how endogenous DMT, occurring naturally in the body, may be useful to modern medicine, particularly by protecting brain cells in the stage of clinical death.<\/p>\n

<\/p>\n

The core assumption of the planned research<\/a> is that one of the physiological roles of endogenous DMT is to protect against oxidative stress, otherwise known as hypoxia or lack of oxygen. In practical terms, the question is whether DMT can be used in a hospital context, to protect patients’ brains against damage caused by oxygen starvation.<\/p>\n

This scenario is most common when patients experience a heart attack or heart failure; usually, such patients are elderly – it can also happen, however, in babies, if the umbilical cord is trapped around the baby's neck. When oxygen is not reaching the brain, the more time passes, the greater the change and extent of brain damage.<\/p>\n